首页> 外文期刊>The International journal of drug policy >A licence to vape: Is it time to trial of a nicotine licensing scheme to allow Australian adults controlled access to electronic cigarettes devices and refill solutions containing nicotine?
【24h】

A licence to vape: Is it time to trial of a nicotine licensing scheme to allow Australian adults controlled access to electronic cigarettes devices and refill solutions containing nicotine?

机译:vape许可证:是否该是时候尝试实施尼古丁许可计划,以使澳大利亚成年人能够控制使用电子烟设备和含有尼古丁的补充溶液?

获取原文
获取原文并翻译 | 示例
           

摘要

Australia has some of the most restrictive laws concerning use of nicotine in e-cigarettes. The only current legal option for Australians to legally possess and use nicotine for vaping is with a medical prescription and domestic supply is limited to compounding pharmacies that prepare medicines for specific patients. An alternative regulatory option that could be implemented under current drugs and poisons regulations is a 'nicotine licensing' scheme utilising current provisions for 'dangerous poisons'. This commentary discusses how such a scheme could be used to trial access to nicotine solutions for vaping outside of a 'medicines framework' in Australia. (c) 2015 Elsevier B.V. All rights reserved.
机译:澳大利亚对电子烟中使用尼古丁有一些限制性最强的法律。澳大利亚人目前合法拥有和使用尼古丁进行雾化的唯一合法选择是开具医疗处方,而国内供应仅限于为特定患者准备药物的复合药房。可以在当前的药物和毒药法规下实施的另一种法规选择是利用现有的“危险毒药”规定的“烟碱许可”计划。这篇评论讨论了如何在澳大利亚的“药物框架”之外使用这种方案来试用获得尼古丁溶液的途径。 (c)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号